Aclarubicin 57576-44-0
| Systematic (IUPAC) name: |
Methyl (1R,2R,4S)-4-[(2R,5S,6S)-4-dimethylamino-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate |
| Aclarubicin CAS number: |
57576-44-0 |
| ATC code: |
L01DB04 |
| PubChem: |
42474 |
| DrugBank: |
|
| Formula: |
C42H53N1O15 |
| Molecular mass: |
811.86 g/mol |
| Aclarubicin Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
